Pivotal trial of Nitric Oxide-Inhalation (NO) in the patients with Mycobacterium Abscessus Complex (MABSC).

Trial Profile

Pivotal trial of Nitric Oxide-Inhalation (NO) in the patients with Mycobacterium Abscessus Complex (MABSC).

Planning
Phase of Trial: Phase III

Latest Information Update: 13 Aug 2018

At a glance

  • Drugs Nitric oxide (Primary)
  • Indications Mycobacterium avium complex infections
  • Focus Registrational; Therapeutic Use
  • Sponsors AIT
  • Most Recent Events

    • 13 Aug 2018 According to an AIT media release, this trial is expected to begin in late 2019.
    • 14 Jun 2018 According to an AIT media release, the company anticipates meeting with the FDA to discuss regarding the design of this pivotal study.
    • 24 Jan 2018 Planned initiation date changed from 1 Jul 2017 to 1 Jul 2018.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top